COMMUNIQUÉS West-GlobeNewswire

Emerald Health Therapeutics Closes $10.8 Million Prospectus Sale

08/12/2018 - 00:11

VICTORIA, British Columbia, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) ("Emerald" or the “Company”) closed today its prospectus sale (the “Offering”) to a single Canadian [...]

Supreme Court of the State of Delaware Rules Against Akorn, New CEO Search Underway

07/12/2018 - 23:04

LAKE FOREST, Ill., Dec. 07, 2018 (GLOBE NEWSWIRE) -- Akorn, Inc. (NASDAQ: AKRX) today said it will move forward and rebuild shareholder value as an independent company following the disappointing decision from the [...]

Revive Announces a $2 Million Non-Brokered Private Placement

07/12/2018 - 23:03

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES TORONTO, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics [...]

In Memoriam: Dr. Andreas Muhs CSO, Scientific Leader and Friend has Passed Away

07/12/2018 - 22:16

Lausanne, Switzerland, December 7, 2018 - AC Immune SA (NASDAQ: ACIU), announced today that its Chief Scientific Officer, Dr. Andreas Muhs, passed away following a period of illness. "It is with great sadness that we [...]

Indiana Minority Health Coalition in partnership with Side Effects Media and The Indianapolis Recorder will host two statewide town hall meetings!

07/12/2018 - 22:13

INDIANAPOLIS, Dec. 07, 2018 (GLOBE NEWSWIRE) -- On December 11, 2018, Indiana Minority Health Coalition in partnership with Side Effects Media and the Indianapolis Recorder will host two statewide virtual town hall [...]

MacroGenics Announces Partial Clinical Hold on MGD009 Phase 1 Studies

07/12/2018 - 22:01

ROCKVILLE, MD, Dec. 07, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]

BIOPHYTIS Announces One Oral Presentation and Two Poster Presentations at the 11th International Conference on Cachexia, Sarcopenia and Muscle Wasting

07/12/2018 - 19:47

PARIS, Dec. 07, 2018 (GLOBE NEWSWIRE) -- BIOPHYTIS (Euronext Growth Paris: ALBPS), a clinical-stage biotechnology company developing first-in-class drug candidates for the treatment of age-related degenerative diseases [...]

ObsEva R&D Day Showcases Multiple Women’s Health Programs and Outlines Plans for Transition to Commercial Operations

07/12/2018 - 18:12

Clinical Trial Data and Regulatory Progress on Lead Programs Targeting IVF, Endometriosis, and Uterine Fibroids to Transform Company in 2019 GENEVA, Switzerland and BOSTON, Mass. (December 7, 2018) – ObsEva SA (NASDAQ: [...]

Affimed Announces U.S. Registrational Pathway and Updated Clinical Development Plan for AFM13 at R&D Day

07/12/2018 - 17:30

- Company to Pursue Registrational Pathway for Lead Agent AFM13 Monotherapy in Patients with Peripheral T Cell Lymphoma with Potential for Accelerated Approval - - Clinical Studies for AFM13 in Combination with anti-PD1 [...]

Tauriga Sciences Inc. to Register Trademark with USPTO to Support Launch of its Cannabis Infused Chewing Gum Product Line

07/12/2018 - 17:29

New York, NY, Dec. 07, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. ( TAUG ) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and licensing of [...]

Tonix Pharmaceuticals Prices $15,000,000 Public Offering

07/12/2018 - 16:35

NEW YORK, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company focused on developing pharmaceutical products to treat [...]

Corruption Widespread in Medical Industry, States the Journal of American Physicians and Surgeons

07/12/2018 - 15:39

TUCSON, Ariz., Dec. 07, 2018 (GLOBE NEWSWIRE) -- Of the more than $3 trillion dollars per year spent worldwide on health services, an untold amount is drained through corruption, according to the non-governmental [...]

OrthoPediatrics Corp. Announces Pricing of Offering of Common Stock

07/12/2018 - 15:24

WARSAW, Ind., Dec. 07, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (Nasdaq: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today the pricing of its [...]

Global Blood Therapeutics Prices a $150.0 Million Common Stock Public Offering

07/12/2018 - 15:15

SOUTH SAN FRANCISCO, Calif., Dec. 07, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (Nasdaq: GBT), a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative [...]

Oxford Immunotec Announces Regulatory Acceptance of T-Cell Select™ in China

07/12/2018 - 15:00

OXFORD, United Kingdom and MARLBOROUGH, Mass., Dec. 07, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced regulatory acceptance of the T-Cell [...]

Site Visit Planned for December 19, 2018 to Initiate Phase 2 Trial of ProscaVax for Early-Stage Prostate Cancer

07/12/2018 - 15:00

BATON ROUGE, La., Dec. 07, 2018 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]

How to Lower Healthcare Costs: Advice to Congress from AAPS President Marilyn Singleton, M.D., J.D.

07/12/2018 - 14:48

TUCSON, Ariz., Dec. 07, 2018 (GLOBE NEWSWIRE) -- Health-related costs have soared from about 5 percent of the average household’s annual spending in 1984 to 8 percent now, writes Marilyn Singleton , M.D., J.D., in the [...]

Re-analysis of CDC Data Suggests Need for Further Investigation on MMR Vaccine and Autism, according to Article in the Journal of American Physicians and Surgeons

07/12/2018 - 14:43

TUCSON, Ariz., Dec. 07, 2018 (GLOBE NEWSWIRE) -- As early as 2001, the Centers for Disease Control and Prevention (CDC) had data showing an increased rate of autism diagnoses in black male schoolchildren in Atlanta who [...]

Prospective Study Demonstrates EndoPredict® Can Guide Chemotherapy Decision For Women with Early-Stage Breast Cancer

07/12/2018 - 14:32

SALT LAKE CITY, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced that academic researchers from the Technical University of Munich (TUM) [...]